Industry Survey Identifies Successful Biotech Clinical Trial Strategies SYDNEY, Australia, May 08, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO conducted a survey of global biotech professionals, in partnership with Citeline, on their...

Novotech Team at BIO Europe to Share Benefits of Expanded Global Operations SINGAPORE, March 07, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO will be at BIO Europe (March 20-22, 2023) to meet with clinical-stage biotechs and to share the...

Experts Share Insights on Evolving Global Vaccine Landscape Including mRNA Trends SINGAPORE, March 03, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials, is convening an expert panel webinar with Endpoints...

Novotech Acquires European CRO – Strengthens Global Operations SINGAPORE, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important...